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Abstract
Background: Human leukocyte antigen DP (HLA-DP) locus has been reported to be associated with hepatitis B virus (HBV)
infection in populations of Japan and Thailand. We aimed to examine whether the association can be replicated in Han
Chinese populations.
Methodology/Principal Findings: Two HLA-DPvariantsrs2395309andrs9277535(themoststronglyassociatedSNPsfromeach
HLA-DP locus) were genotyped in three independent Han cohorts consisting of 2 805 cases and 1 796 controls. By using logistic
regression analysis, these twoSNPs in the HLA-DPA1 and HLA-DPB1 genes were significantly associated with HBV infection in Han
Chinese populations (P=0.021,3.36610
28 at rs2395309; P=8.37 610
23,2.68610
210 at rs9277535). In addition, the genotype
distributions of both sites (rs2395309 and rs9277535) were clearly different between southern and northern Chinese population
(P=8.95610
25 at rs2395309; P=1.64610
29 at rs9277535). By using asymptomatic HBV carrier as control group, our study
showed that there were no associations of two HLA-DP variants with HBV progression (P=0.305,0.822 and 0.163,0.881 in
southern Chinese population, respectively; P=0.097,0.697 and 0.198,0.615 in northern Chinese population, respectively).
Conclusions: Our results confirmed that two SNPs (rs2395309 and rs9277535) in the HLA-DP loci were strongly associated
with HBV infection in southern and northern Han Chinese populations, but not with HBV progression.
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Introduction
More than 2 billion people have been infected with the hepatitis
B virus (HBV) worldwide, of which 350 million are chronic
carriers and about 600 000 die annually of HBV-related acute or
chronic liver disease [1]. Although many individuals eventually
achieve a state of nonreplicative infection, the prolonged
immunologic response to infection leads to the development of
cirrhosis, liver failure, or hepatocellular carcinoma (HCC) in up to
40% of patients [2]. In China, where HBV infection is endemic,
there are estimated 93 million HBV carriers, and among them 30
million are patients with chronic hepatitis B [3]. Multiple causes
influence the risk of chronic HBV infection in china, for example,
age, gender, viral genotype, ethnicity, variation in genes of the
immune system and so on [4].
Several polymorphisms of the HLA loci have been reported for
hepatitis B virus infection [5,6]. A study in Gambian found that
the allele DRB1*1302 was associated with the clearance of the
virus [7]. Hepatitis B virus persistence and disease chronicity were
associated with HLA-DQA1*0501 and HLA-DQB1*0301 in Chi-
nese [8] and with HLA-DR9 in Koreans [9]. Although the
association between common diseases and these HLA (or non-
HLA) genes has become increasingly evident [10], their results are
conflicting among the studies, and have not been confirmed by
other investigators [11].
A recent study found that the HLA-DP locus was associated with
chronic hepatitis B in Japanese and Thais [12]. As the frequencies
of these HLA-DP alleles in Chinese populations were similar to
those in Japanese populations, it would be necessary to confirm
whether there was the association between the HLA-DP genetic
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we selected the most strongly associated SNPs (the previous
GWAS results) from each HLA-DP locus (rs9277535 at the HLA-
DPB1 and rs2395309 at the HLA-DPA1, respectively) and
genotyped these two polymorphisms in a population-based case-
control study of Chinese Hans, including 2 805 cases and 1 796
controls from Hubei province (Central China), Shandong province
(North China) and Guangdong province (South China).
Materials and Methods
Ethic statement
The study was approved by the local research ethics committee
(REC) at the Tongji Hospital of Huazhong University of Science
and Technology in accordance with the principle of the Helsinki
Declaration II. All written informed consent documents from each
participant were obtained during the enrollment phase.
Study subjects
A total of 4 601 unrelated Han Chinese were recruited in this
study between September 2007 and June 2011. All subjects were
divided into six groups: a) HBV clearance group(Clear); b) Healthy
control group(Health); c) Persistent asymptomatic HBV carriers
group(AsC); d) Chronic active hepatitis B group(CHB); e) HBV-
related liver cirrhosis group(LC); and f) HBV-related heptocellular
carcinoma group(HCC). The diagnostic criteria for study inclusion
were listed in Table S1, which had been described in the previous
publication [13,14]. All individuals were gathered from three Han
Chinese cohorts. First, we recruited 2 280 subjects from Tongji
hostital and Union hospital in Wuhan, Hubei province. Second,
we gathered additional 1 304 subjects from The Affiliated
Hospital of Binzhou Medical College and Qingdao Infectious
Disease Hospital in Shandong province, 1 017 subjects from
Shenzhen Third People’s Hospital, Shenzhen Fourth People’s
Hospital and Shenzhen Sixth People’s Hospital in Guangdong
province.
A uniform questionnaire was used at three enrollment sites and
recorded self-report of risk factors for HBV transmission, family
history of HBV infection, past and current smoking, alcohol
ingestion, etc. The demographic information included gender,
birth-date, birthplace, and past and current residency.
DNA Isolation and Genotyping
Genomic DNA was isolated from peripheral whole blood using
TIANamp blood DNA kit (Tiangen Biotech [Beijing] Co., Ltd.,
China). The concentration and purity of the DNA were
determined with a NanoDrop spectrophotometer and diluted to
a final concentration of 8 ng/mL. The genotyping of genetic
polymorphisms was performed via the TaqMan method according
to the protocol of TaqManH SNP Genotyping Assays (Applied
Biosystems, California, USA). Allelic category was measured
automatically using the Sequence Detection System 2.3 software
(Applied Biosystems) according to the intensity of VIC and FAM
dye. To detect these SNPs (rs2395309 and rs9277535), we
customized the TaqManH MGB Probe as well as the primers for
PCR amplification (Table S2.).
Statistical analysis
Statistical analysis was conducted by using haploview 4.2,
Arlequin 3.5, Stata10.0 and SPSS 17.0 softwares. Linkage
disequilibrium was assessed by the haploview 4.2 softwares using
frequencies obtained from the Health group. The (Bayesian) ELB
algorithm was used to infer haplotypes by using Arlequin 3.5. The
Hard-Weinberg equilibrium of alleles and population pairwise
comparisons were also evaluated by using Arlequin 3.5 [15]. A
meta-analysis of all studies was performed for each SNP associated
with chronic hepatitis B by using Stata10.0 softwares. Odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated on the
basis of the binary logistic regression analysis (adjustment for
gender and age). The strength of association between the
genotypes or alleles and HBV infection was estimated by using
SPSS 17.0 softwares. A best-fit model was constructed by means of
comparisons with other models. Values of P,0.05 were
considered statistically significant.
Results
Hardy-Weinberg equilibrium test
Hardy-Weinberg equilibrium was estimated by Fisher’s exact
test using Arlequin 3.5 software. There was no significant
difference between observed and expected frequencies of each
genotype in these involved populations (P.0.05). This result
indicated that these populations had a relatively stable genetic
background and were suitable for further genetic statistical
analysis.
The clinic and demographic characteristics
The clinical and demographic characteristics of the case-control
study were summarized in Table 1, including gender, age,
drinkers, serum total bilirubin level (T-Bil), HBV-DNA load,
alanine transaminase (ALT) and serum markers of hepatitis B
virus. There was no significant difference in the percentage of
hepatitis B e antigen (HBeAg) positive (P=0.10) between
asymptomatic HBV carriers (17.1%) and the patients of chronic
hepatitis B group (20.2%). In addition, there was more alcohol
consumption in patients (P,0.05) with HBV-related liver cirrhosis
group (24.3%) and HBV-related heptocellular carcinoma group
(30.5%) than those in HBV clearance group (10.2%) and healthy
control group (8.9%). The difference in the alcohol consumption
status was due to few drinkers in Chinese female population.
Although an effort was made to obtain a good match on age and
sex, there were more men in four case groups (averaged 73.5%)
than those in HBV clearance group (51.6%, P,0.05) and healthy
control group (47.5%, P,0.05).
Population pairwise comparisons and grouping of
subjects
To explore whether differences in susceptibility loci were caused
by the disease or by genetic background between populations, we
first needed to determine which populations should be compared
with each other, and whether there were populations that could be
lumped together to simplify statistical analysis. To this end, we
performed population pairwise comparisons FST testing between
each population using Arlequin 3.5 software. The principle of
population pairwise comparisons states that: if there is no
difference in heredity between two populations, the data
permuting of genotypes or haplotypes between two populations
should not cause a significant difference, which can be evaluated
by FST P value (P.0.05). According to the results shown in
Table 2, we could infer that Shandong population had greater
difference than Hubei population or Guangdong population in
genetic background (P,0.0001). As the pairwise comparisons for
Hubei population and Guangdong population were not signifi-
cantly different (P=0.191), and both of them were the same
geographic position (southern of china) [16], we had determined to
merge Hubei population and Guangdong population into
southern Chinese population. Meanwhile, Shandong population
was taken as northern Chinese population. Furthermore, in order
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HBV infection or clearance, we combined all the types of HBV
infection populations into one group by using the healthy group or
clearance group as the reference.
Logistic regression analysis of the HLA-DP loci
polymorphisms
Then, to investigate which genotypic models were significantly
associated with the various outcomes, we conducted comparisons
of four models (Multiplicative model, Additive model, Dominant
model and Recessive model) in southern and northern Chinese
populations respectively (data not show). For the four models, the
best-fit genotypic effect of these two SNPs (rs2395309 and
rs9277535) was observed in the dominant model which was the
protective genotype AA and AG (see Table 3). After compared
with the Healthy control group, both single nucleotide polymor-
phism (SNP) sites (rs2395309 and rs9277535) showed associations
with HBV infection in southern Chinese population (Odds ratio
[OR]=0.57; 95% Confidence intervals [CI] :0.47, 0.70;
P=3.36610
28 at rs2395309; OR=0.52; 95% CI :0.43, 0.64;
P=2.68610
210 at rs9277535), as well as in northern Chinese
population (OR=0.50; 95% CI :0.35, 0.71; P=1.23610
24 at
rs2395309; OR=0.50; 95% CI :0.36, 0.68; P=1.74610
25 at
rs9277535). And, interestingly, HLA-DP rs2395309 and rs9277535
sites also showed a strong protective effect for HBV clearance not
only in southern Chinese population (OR=1.31; 95% CI :1.17,
1.45; P=9.63610
27 at rs2395309; OR=1.33; 95% CI :1.20,
1.49; P=1.67610
27 at rs9277535) but also in northern Chinese
population (OR=1.20; 95% CI :1.03, 1.40; P=0.021 at
rs2395309; OR=1.26; 95% CI :1.06, 1.49; P=8.37610
23 at
rs9277535). As shown in Table 3, notably, the genotype
distributions of both sites (rs2395309 and rs9277535) were clearly
different between southern and northern Healthy populations (P
values=8.95610
25 and 1.64610
29, respectively. P values of
Pearson’s x
2 test for allele model). The two minor-allele
frequencies (MAF) in both Healthy populations (southern and
northern Han Chinese) were 30.1% vs 38.8% at rs2395309,
38.1% vs 52.2% at rs9277535. In addition, to decrease the bias of
sex and age in population sampling, we further conducted the
stratified analysis for sex and age. As presented in Table S3, male
and female patients showed different associations with HBV
diseases in these two SNPs (rs2395309 and rs9277535). Specially,
in the northern Chinese population, this difference was notable
between male patients and female patients. Furthermore, in the
stratified analysis of age, most cases were no significant differences
in genotype distributions of two SNPs sites between patients with
age#45 years and patients with age.45 years (Table S4.).
Associations of the HLA-DP loci polymorphisms with HBV
progression
Considering the function of HLA-DP molecules, we were
interested in the possible association between the polymorphisms
in HLA-DP gene and the disease progression of chronic hepatitis B.
To test our prediction, we further analysed the difference in two
SNPs genotype distributions by using asymptomatic HBV carrier
as control group. Unfortunately, there were not associations in
chronic active hepatitis B group (OR=1.03; 95% CI : 0.79, 1.34;
P=0.822 at rs2395309; OR=0.92; 95% CI : 0.71, 1.18; P=0.501
at rs9277535, in southern Chinese population; OR=0.92; 95%
CI : 0.62, 1.38; P=0.697 at rs2395309; OR=1.33; 95% CI : 0.86,
2.06; P=0.198 at rs9277535, in northern Chinese population),
Table 1. Clinical characteristics of study subjects.
Characteristics Health(n=962) Clear(n=834) AsC(n=910) CHB(n=964) LC(n=544) HCC(n=387)
Gender, no. (%)
Male 454(47.5) 421(51.6) 519(58.4) 765(81.0) 435(80.3) 342(88.8)
Female 501(52.5) 395(48.4) 370(41.6) 180(19.0) 107(19.7) 43(11.2)
Age (years), mean(sd) 51.70610.96 51.48611.04 45.64610.93 38.45610.73 48.30611.02 49.82610.01
Drinkers, no. (%) 86(8.9) 85(10.2) 102(11.2) 179(18.6) 132(24.3) 118(30.5)
HBsAg All2 All2 All+ All+ All+ All+
Anti-HBs IgG All2 All+ All2 All2 All2 All2
HBeAg-positive,no. (%) All2 All2 156(17.1) 195(20.2) 64(11.8) 39(10.1)
Anti-HBc IgG, no. (%) All2 All+ All+ All+ All+ All+
Family history, no. (%) No No 36(4.0) 142(14.7) 69(12.7) 77(19.9)
ALT(U/L) No No 19.74615.09 447.536402.71 101.576119.90 83.64686.17
TBil (mmol/L) No No 11.7169.01 161.556171.06 124.196125.86 69.24665.74
HBV-DNA (copy/ml) No No No 3.23E764.76E7 1.38E665.16E6 3.72E661.13E7
‘No’ means non-detected.
‘Drinkers’ was defined as alcohol consumption of .40 g/week, which included occasional drinkers and daily drinkers.
Abbreviations: Clear, HBV clearance group; Health, Healthy control group; AsC, Asymptomatic HBV carriers group; CHB, Chronic active hepatitis B group; LC,HBV-related
liver cirrhosis group; HCC, HBV-related heptocellular carcinoma group;
doi:10.1371/journal.pone.0024221.t001
Table 2. Matrix of significant FST P values among populations.
Populations Hubei Guangdong Shandong
Hubei *
Guangdong 0.191 *
Shandong ,0.0001 ,0.0001 *
Population pairwise comparisons FST tests were performed between pairs of
groups using Arlequin 3.5software. Statistically significant values are in shown
in bold.
Abbreviations: Hubei, Hubei populations; Guangdong, Guangdong populations;
Shandong, Shandong populations.
doi:10.1371/journal.pone.0024221.t002
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1.52; P=0.499 at rs2395309; OR=1.24; 95% CI : 0.92, 1.67;
P=0.163 at rs9277535, in southern Chinese population;
OR=0.74; 95% CI : 0.48, 1.16; P=0.189 at rs2395309;
OR=1.29; 95% CI : 0.81, 2.06; P=0.286 at rs9277535, in
northern Chinese population) and HBV-related heptocellular
carcinoma group(OR=0.85; 95% CI : 0.63, 1.16; P=0.305 at
rs2395309; OR=0.98; 95% CI : 0.73, 1.31; P=0.881 at
Table 3. Associations of two SNPs (rs2395309, rs9277535) with HBV infection and clearance in Han Chinese populations.
South of china North of china
Control group Case group Control group Case group
HLA-DPB1 (rs2395309)- dominant model (AA+AGvsGG)
AA/AG/GG 57/234/288
{ 112/709/1367
{ 52/193/138
{ 63/249/302
{
P value OR (95%CI) Reference 3.36610
28 0.57 (0.47,0.70) Reference 1.23610
24 0.50 (0.35,0.71)
AA/AG/GG 112/709/1367
{ 35/235/257
I 63/249/302
{ 56/130/121
I
P value OR (95%CI) Reference 9.63610
27 1.31 (1.17,1.45) Reference 0.021 1.20 (1.03,1.40)
HLA-DPA1 (rs9277535)- dominant model (AA+AGvsGG)
AA/AG/GG 80/277/216
{ 177/830/1195
{ 97/203/80
{ 118/287/206
{
P value OR (95%CI) Reference 2.68610
210 0.52 (0.43,0.64) Reference 1.74610
25 0.50 (0.36,0.68)
AA/AG/GG 177/830/1195
{ 67/251/208
I 118/287/206
{ 67/165/75
I
P value OR (95%CI) Reference 1.67610
27 1.33 (1.20,1.49) Reference 8.37610
23 1.26 (1.06,1.49
{Healthy control group.
IHBV clearance group.
{HBV infection groups, including Asymptomatic HBV carriers, Chronic active hepatitis B group, HBV-related liver cirrhosis group, HBV-related heptocellular carcinoma
group.
The P values, odds ratios (OR), and 95% confidence intervals (CI) were calculated on the basis of the binary logistic regression analysis, adjusted for sex and age.
doi:10.1371/journal.pone.0024221.t003
Table 4. Results of the association test for two SNPs(rs2395309,rs9277535) haplotypes in Han Chinese populations.
South of china
Haplotype Health(2n=1106) Clear(2n=1048) AsC(2n=1342) CHB(2n=1486) LC(2n=754) HCC(2n=632)
A-A 247(22.3) 205(17.0) 227(16.8) 238(16.0) 122(16.2) 92(14.5)
A-G 88(8.0) 97(11.8) 62(4.6) 95(6.4) 36(4.8) 23(3.7)
G-A 173(15.6) 177(19.5) 140(10.4) 143(9.6) 95(12.6) 78(12.4)
G-G 598(54.1) 569(51.7) 913(68.1) 1010(68.0) 501(66.4) 439(69.4)
P value
II¯ Reference 1.47610
26 6.47610
28 2.53610
25 6.07610
27
OR (95%CI) 0.60 (0.49,0.74) 0.57 (0.47,0.70) 0.59 (0.46,0.76) 0.51 (0.39,0.66)
P value
II ¯ Reference 7.35610
24 8.92610
25 2.45610
23 1.06610
24
OR (95%CI) 1.45 (1.17,1.80) 1.53 (1.24,1.89) 1.48 (1.15,1.91) 1.72 (1.31,2.27)
North of china
Haplotype Health(2n=734) Clear(2n=608) AsC (2n=422) CHB (2n=378) LC(2n=300) HCC(2n=100)
A-A 226(30.8) 200(31.5) 118(28.0) 103(27.3) 71(23.6) 21(20.5)
A-G 55(7.5) 41(8.1) 27(6.4) 18(4.8) 16(5.4) 4(3.5)
G-A 157(21.4) 98(17.5) 66(15.6) 60(15.9) 62(20.7) 15(15.4)
G-G 296(40.3) 269(42.9) 211(50.0) 197(52.1) 151(50.3) 60(60.5)
P value
II¯ Reference 0.032 0.012 0.004 0.003
OR (95%CI) 0.73 (0.55,0.97) 0.68 (0.51,0.92) 0.62 (0.44,0.86) 0.46 (0.27,0.78)
P value
II ¯ Reference 0.054 0.021 0.007 0.005
OR (95%CI) 1.33 (0.99,1.78) 1.42 (1.05,1.92) 1.58 (1.13,2.21) 2.12 (1.25,3.61)
II¯Two SNPs haplotypes G-G, A-A in Health group compared with those in HBV infection groups.
II ¯ Two SNPs haplotypes G-G, A-A in HBV infection groups compared with those in Clearance group.
The P values, odds ratios (OR), and 95% confidence intervals (CI) were calculated by Pearson Chi-Square test.
Abbreviations: Clear, HBV clearance group; Health, Healthy control group; AsC, Asymptomatic HBV carriers group; CHB, Chronic active hepatitis B group; LC,HBV-related
liver cirrhosis group; HCC, HBV-related heptocellular carcinoma group; OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0024221.t004
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0.28, 1.11; P=0.097 at rs2395309; OR=0.84; 95% CI : 0.42,
1.68; P=0.615 at rs9277535, in northern Chinese population),
compared with asymptomatic HBV group(Table S5.).
Associations of the HLA-DP loci polymorphisms with
clinical factors
In order to analyze the associations between two SNPs and
clinical factors (HBV-DNA load, ALT and TB), we used the
independent-sample Kolmogorov-Smirnov t test in CHB group,
LC group and HCC group. Although the GG patients have a
higher mean on the HBV-DNA load, no significant difference was
found between patients of different genotypes (see Fig. S1). In the
analysis of ALT, the associations between two SNPs and the ALT
level only be found in HBV-related liver cirrhosis group (P=0.002
at rs2395309; P=0.009 at rs9277535), rather than in other
groups. Meanwhile, for the associations of the TB level, there was
no difference between GG patients and AG+AA patients (P.0.05
in each group).
Results of the Haplotype analysis and Meta-analysis
To further understand the contributions of these loci to HBV
susceptibility, two-locus haplotypes were constructed for two SNPs
rs2395309 and rs9277535 (Table 4.). Pairwise linkage disequilib-
rium (LD) analyses performed using all individuals from the health
group showed that rs2395309 and rs9277535 SNPs were in LD
with each other (D9=0.57, r
2=0.23 in southern Chinese
population; D9=0.58, r
2=0.20 in northern Chinese population).
In trying to derive HBV infection-specific haplotypes, the
haplotype frequencies of two SNPs (rs2395309 and rs9277535)
were evaluated in both Chinese populations. Four haplotypes were
observed, and among them three haplotypes had frequencies more
than 5% (Table 4.). Compared with protective A-A haplotype
homozygotes, only G-G haplotype homozygotes had a significant
increased risk for HBV infection (P value and odds ratios were
shown in Table 4). Then, we summarized a meta-analysis
combined with the results of related studies [12,17], including
more than 2,243 cases and 4,137 controls. As shown in Figure 1
and Table S6, these odds ratios were quite similar among the three
ethnic groups (Japanese, Thais and Chinese) and no heterogeneity
was observed (P het=0.673 at rs2395309; P het=0.882 at rs
9577535).
Discussion
In this analysis, we confirmed that two SNPs sites (rs2395309
and rs9277535) in the HLA-DPA1 and HLA-DPB1 genes were
significantly associated with HBV infection in southern and
northern Han Chinese populations. Again, our haplotype analysis
showed the frequency of G-G haplotype had a significant increase
in the HBV infected populations, as compared with the healthy
control group or HBV clearance group. As a result, we inferred
that these persons with G-G haplotype have a higher risk of HBV
infection than those persons with A-A haplotype. Meanwhile, the
A-A haplotype could be strongly predictive for HBV clearance in
HBV infection populations. Although our manuscript suggested
that the genotype distributions of both sites (rs2395309 and
rs9277535) were different between southern and northern Chinese
population, the frequencies of two protective alleles A in Chinese
populations were also similar to those in Asian populations,
compared with European and Central American populations (data
from public databases, HapMap). The results of the genetic
association in our study were consistent with the previous study
[12]. Hence, we could confirm that the polymorphisms of HLA-
DPA1 and HLA-DPB1 gene play a very important role in chronic
hepatitis B virus infection in southern and northern Han Chinese
populations.
Figure 1. Meta-analasis of the rs9277535 and rs2395309. The meta-analysis combined with the results of previous studies, including more
than 2,243 cases and 4,137 controls. Each effect size is shown with its confidence interval. Abbreviations: p, P heterogeneity value; OR, odds ratios;
95%CI, 95% confidence interval.
doi:10.1371/journal.pone.0024221.g001
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women to be infected with HBV and develop liver cirrhosis and
hepatocellular carcinoma [18,19]. The reasons for the gender
distinction between HBV populations and health populations are
complex, including occupation, alcohol drinking, tobacco smok-
ing, family history of HBV infection and so on. Some previous
reports suggested that sex hormones might interact with HBV in
the infection process and lead to a dominant sex disparity in HBV
populations. Naugler et al. [20] found that estrogen-mediated
inhibition of interleukin-6 production by Kupffer cells reduced the
risk of liver cancer in females. Wang et al. [21] study demonstrated
that the androgen pathway could increase the transcription of
HBV through direct binding to the androgen-responsive element
sites in viral enhancer. Consequently, to decrease the bias of sex in
population sampling, we further conducted the stratified analysis
for sex. Although we found that male and female northern
Chinese showed a different susceptibility to HBV infection, it only
had 25% and 21% statistical power to detect these ORs of 0.73
and 0.74, which may lead to the false-negative results of rs2395309
and rs9277535 in northern female Chinese. The small sample for
female HBV patients in this study might be the major reason for
the non-significant associations in female Chinese. Hence, we only
concluded that the genetic variants of HLA-DPA1 and HLA-DPB1
loci differ slightly between male and female Chinese, and the
reasons why there is different between male and female for HBV
infection need to be further studied.
And indeed, by consulting previous studies [22,23], we found
that there are different distributions in some HLA alleles among
Han Chinese populations. For instance, HLA-DRB1*0301 [8], a
risk-allele with respect to chronic HBV infection in Han Chinese,
markedly has higher frequency in southern Han Chinese
population than those in northern Han Chinese population. Since
the frequency distribution of HLA-DP alleles were barely reported
in China, it could be inferred only indirectly that there were also
different distributions at HLA-DP alleles between two Han Chinese
populations. And, it was the difference that led to the distinct
distributions of both SNPs (rs9277535 and rs2395309) between
southern and northern Han Chinese population. Nevertheless, this
explanations why the distributions of the HLA alleles (or SNPs)
differed between Han Chinese populations were complicated, such
as evolution and migration history of the Chinese population
[24,25,26], MHC-based mate choice [27], pathogen-driven
selection at HLA alleles [28,29] and so on. Taking into account
the different distributions of HBV genotypes [30] and HBV carrier
rate [31] in China, as well as recent studies [12,17] and our results,
we deduced that the mechanism of pathogen-driven selection
(HBV and/or other pathogens) might be the leading cause of the
different distributions at HLA-DP alleles between two Han Chinese
populations.
Moreover, after infection with hepatitis B virus (HBV), the host’s
inflammatory immune response induces hepatocellular damage and
is followed by the pathogenesis of liver cirrhosis and cancer [32].
Liver cancer arises most frequently in the setting of chronic liver
inflammation [33]. Considering the function of HLA-DP molecules,
HBV antigenpresentation on HLA-DP molecules may be critical for
virus elimination and has an important role in the progression of
hepatitis B [34]. Therefore, we further analysed the possible
association between the polymorphisms in HLA-DP gene and the
disease progression of chronic hepatitis B. Unfortunately, compared
with asymptomatic HBV carrier, there were no associations in
chronic active hepatitis B group, HBV-related liver cirrhosis group
and HBV-related hepatocellular carcinoma group. Although
chronic HBV infection is the most important cause of HCC
worldwideandcontributestoatleast70%ofcasesofHCCinAsian-
Africa [35], only a tiny fraction of chronic HBV carriers develop
HCC in their lifetime [36]. It is suggested that the risk of HCC is
caused by a complex interplay between multiple genetic and
environmental factors. Recently, Zhang et al. have conducted the
first liver GWAS for HCC in Chinese ancestry and identified a
single susceptibility locus in the UBE4B-KIF1B-PGD region on
1p36.22 [37]. Since the region involve in these aspects of vesicles
transport, cell apoptosis, DNA repair, and other intracellular
pathways, it seems likely that different genes play disparate roles in
HBV infection and HBV progression. For example, immune
pathway (HLA-DP or other genes) is the primary cause of HBV
infection, but intracellular pathway (Ubiquitin or other pathways) is
the major reason of HBV progression. Thus, by combining our
results with the aforementioned discussion, we inferred that the
polymorphisms in HLA-DPA1 and HLA-DPB1 gene influence the
infection of HBV in Chinese populations, rather than the
progression of HBV disease.
Since the early 1970s [38], classical human leukocyte antigen
loci have stood out as the leading candidates for infectious disease
susceptibility. The classical HLA loci are the class I (HLA-A, -B, -C,
-E, -F, and -G) and class II (HLA-DR, -DQ, -DM, and -DP)
molecules. HLA class II molecules are the central part in the
immune system by presenting peptides to the antigen receptor of
CD4+ T cells [39]. Antigen presentation is not only crucial for the
regulation of protective immune responses against invading
pathogens, but also necessary for the maintenance of self-
tolerance. It is therefore perhaps not surprising to find that the
human MHC class II gene region holds the largest number, and
some of the longest recognised, associations with a autoimmune,
inflammatory and infectious diseases [40,41]. Although HLA-DPs
have a structure similar to other classical HLA class II molecules,
HLA-DP molecule roles in the immune response have not been
well characterized until now. In a previous study, Hirayama et al.
[42] indicated that the HLA class II genes for the HLA-DR-DQ
alleles were associated with protection against early changes in
liver fibrosis, whereas HLA-DP alleles were associated with
protection from the late phase of schistosomal hepatic fibrosis.
Owing to lack of replication of the previously report, more studies
are essential to provide conclusive genetic and functional evidence
to support a role for HLA-DP in HBV disease susceptibility.
In summary, in this multicenter case-control study, we have
confirmed that the G alleles of two SNPs sties in the HLA-DPA1
and HLA-DPB1 were significantly associated with hepatitis B virus
(HBV) infection in Han Chinese populations, and both A alleles
(rs2395309 and rs9277535) also showed a strong protective effect
for HBV clearance. Furthermore, we found that the genotype
distributions of both sites (rs2395309 and rs9277535) were clearly
different between southern and northern Han Chinese population.
By using asymptomatic HBV carrier as control group, our study
showed that there were no associations of HLA-DP variants
(rs2395309 and rs9277535) with HBV progression. Although
HBV disease is not determined solely by genetic factors, the
experimental results offer the foundation for further study of
genetic variations in the HLA-DPA1 and HLA-DPB1 for the
prevention and therapy of chronic HBV infection.
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